Sanofi (NASDAQ:SNY) Reaches New 12-Month Low – Here’s What Happened

Shares of Sanofi (NASDAQ:SNY) hit a new 52-week low on Thursday . The stock traded as low as $42.26 and last traded at $42.4420, with a volume of 52797 shares trading hands. The stock had previously closed at $42.50.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on SNY shares. BNP Paribas Exane lowered Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 price target for the company. in a research report on Monday, April 20th. Morgan Stanley set a $52.00 price target on Sanofi in a research report on Friday, May 1st. Weiss Ratings upgraded Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, May 13th. Citigroup reiterated a “neutral” rating on shares of Sanofi in a research report on Monday, April 13th. Finally, Sanford C. Bernstein upgraded Sanofi to a “strong-buy” rating in a research report on Thursday, March 19th. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat.com, Sanofi has a consensus rating of “Hold” and an average price target of $51.00.

Sanofi Stock Performance

The firm has a 50 day moving average of $44.88 and a 200-day moving average of $46.39. The stock has a market capitalization of $101.77 billion, a PE ratio of 11.73, a P/E/G ratio of 1.09 and a beta of 0.34. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.22 and a current ratio of 1.01.

Sanofi Increases Dividend

The firm also recently disclosed an annual dividend, which was paid on Wednesday, June 3rd. Investors of record on Monday, May 4th were paid a $2.4225 dividend. The ex-dividend date of this dividend was Monday, May 4th. This represents a yield of 559.0%. This is an increase from Sanofi’s previous annual dividend of $2.04. Sanofi’s dividend payout ratio (DPR) is currently 49.16%.

Institutional Investors Weigh In On Sanofi

Hedge funds and other institutional investors have recently made changes to their positions in the company. Flagship Harbor Advisors LLC purchased a new stake in shares of Sanofi during the 4th quarter worth about $25,000. Physician Wealth Advisors Inc. raised its stake in shares of Sanofi by 180.5% during the 1st quarter. Physician Wealth Advisors Inc. now owns 589 shares of the company’s stock worth $28,000 after purchasing an additional 379 shares in the last quarter. Leonteq Securities AG raised its stake in shares of Sanofi by 95.8% during the 1st quarter. Leonteq Securities AG now owns 607 shares of the company’s stock worth $29,000 after purchasing an additional 297 shares in the last quarter. Western Wealth Management LLC purchased a new stake in shares of Sanofi during the 1st quarter worth about $29,000. Finally, Measured Wealth Private Client Group LLC purchased a new stake in shares of Sanofi during the 3rd quarter worth about $29,000. 14.03% of the stock is owned by hedge funds and other institutional investors.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.